Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ZNTLZNTL
Showing 8 of 25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ZENTALIS PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 2.3M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), worth $11.1M as of 2026-Q2. The position was increased (+32.7% shares). ZNTL represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$11.1M

Current Shares

2.3M

Total Value Change

+$1.1M

Total Shares Change

-419,118

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+32.7%
$11.1M0.0%$4.85
36
2026-Q1
Decreased
1.7M
-11.8%
$4.1M0.0%$2.38
0
2025-Q4
Decreased
2M
-5.4%
$2.7M0.0%$1.33
0
2025-Q3
Increased
2.1M
+349.3%
$3.1M0.0%$1.49
43
2025-Q2
Increased
462,340
+550.6%
$536,3140.0%$1.18
39
2025-Q1
Decreased
71,058
-97.8%
$112,9820.0%$1.81
0
2024-Q4
Increased
3.2M
+18.4%
$9.7M0.0%$2.92
32
2024-Q3
Decreased
2.7M
-39.6%
$10M0.0%$3.75
0

Other major holders of ZNTL: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used